Ministère de la Santé et de la Lutte contre le Sida (MSLS), Ministère d’État, Ministère du Plan et du Développement of the Institut National de la Statistique (INS) [Côte d'Ivoire] and ICF International., Minnesota Population Center
429) Did you get the (SP/Fansidar) during any antenatal care visit, during another visit to a health facility, or from another source?
ANTENATAL VISIT 1
ANOTHER FACILITY VISIT 2
OTHER SOURCE 6
Categories
Value
Category
1
Antenatal visit
2
Another facility visit
3
Other source
8
Missing
9
NIU (not in universe)
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Description
Definition
For children born in the five years before the survey to women who received antenatal care and took SP/Fansidar while the child was in utero, ANMALSPSRC (ML2) indicates whether the SP/Fansidar came from an antenatal care visit, another visit to a health facility, or from some other source. This drug is used to treat malaria.